(Q40545174)

21 September 2017

title

Antibiotic prophylaxis with meropenem after allogeneic stem cell transplantation (English)

1 reference

21 September 2017

1 reference

Pérez-Simón JA

1

1 reference

21 September 2017

García-Escobar I

2

1 reference

21 September 2017

Martinez J

3

1 reference

21 September 2017

Vazquez L

4

1 reference

21 September 2017

Caballero D

5

1 reference

21 September 2017

Cañizo C

6

1 reference

21 September 2017

Mateos MV

7

1 reference

21 September 2017

San Miguel JF

8

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

Bone Marrow Transplantation

21 September 2017

published in

1 reference

21 September 2017

volume

33

1 reference

21 September 2017

issue

2

1 reference

21 September 2017

page(s)

183-187

1 reference

Antimicrobial prophylaxis in bone marrow transplantation

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704335

The colony stimulating factors. Discovery, development, and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704335

Granulocyte-macrophage colony-stimulating factor (GM-CSF) as an adjunct to autologous hemopoietic stem cell transplantation for lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704335

Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704335

Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704335

Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia. The trade-off for reduced gram-negative sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704335

Prophylactic co-trimoxazole versus norfloxacin in neutropenic children--perspective randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704335

Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704335

Oral ciprofloxacin as antibacterial prophylaxis after allogeneic bone marrow transplantation: a reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704335

Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704335

Emergence of quinolone-resistant Escherichia coli bacteremia in neutropenic patients with cancer who have received prophylactic norfloxacin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704335

Emergence of ciprofloxacin-resistant coagulase-negative staphylococcal skin flora in immunocompromised patients receiving ciprofloxacin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704335

Bacteremia due to fluoroquinolone-resistant Escherichia coli in two immunocompromised patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704335

Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704335

High-level quinolone resistance amongst clinical isolates of Escherichia coli and Klebsiella pneumoniae from Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704335

Norfloxacin for prevention of bacterial infections during severe granulocytopenia after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704335

Efficacy and tolerability of prophylactic treatment with intravenous piperacillin/tazobactam in patients undergoing hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704335

Streptococcus mitis sepsis in bone marrow transplant patients receiving oral antimicrobial prophylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704335

Outbreak of coagulase negative staphylococcus highly resistant to ciprofloxacin in a leukaemia unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704335

Randomized trial of the addition of gram-positive prophylaxis to standard antimicrobial prophylaxis for patients undergoing autologous bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704335

A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704335

Prevalence of penicillin-resistant viridans streptococci in healthy children and in patients with malignant haematological disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704335

Considerations for the prevention of infectious complications in patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704335

7 January 2021

Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704335

7 January 2021

Human recombinant GM-CSF in allogeneic bone-marrow transplantation for leukaemia: double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704335

7 January 2021

Prophylaxis of bacterial infections with ciprofloxacin in patients undergoing bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704335

7 January 2021

Granulocyte colony-stimulating factor (G-CSF) with or without a quinolone in the prevention of infection in cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704335

7 January 2021

Emergence of ciprofloxacin resistance in Escherichia coli isolates after widespread use of fluoroquinolones

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704335

7 January 2021

Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704335

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704335

1 reference

Dimensions Publication ID

21 September 2017

1046411908

0 references

1 reference